< Back to companies
DoMore Diagnostics

DoMore Diagnostics

Oslo, Norway

DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective. To best treat cancer, we must understand how the disease will develop. The Histotype Px® Colorectal marker is able to predict the outcome of a patient’s cancer and can guide a more precise treatment for each patient, and thereby avoid over-and undertreatment. Histotype Px® Colorectal* cancer marker is the most advanced deep convolutional neural network algorithm for determining prognosis in colorectal cancer based on standard histology images.

Share
Shareable draft
Get Involved in DoMore Diagnostics

Company Info

Founded
2020
Website
www.domorediagnostics.com/

Categories

CancerDiagnosticsAI / MLPathology

Disease Areas

Technologies

AI/Machine LearningDeep LearningNeural NetworksDigital Pathology
Only accessible to MedStartr community members. Join now

What do you think of DoMore Diagnostics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in DoMore Diagnostics
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free